Alprazolam: all 64 studies that test it
Page 1 of 1. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.
- Role of Alprazolam in Management of Post Endodontic Pain After Single Visit Root Canal Treatment. To Compare Mean Pain Score Between Two Group of Participants Undergoing Post Operative Pain Management After Single Visit Root Canal Treatment: NSAIDs Alone and a Combination of NSAIDs and Alprazolam.RecruitingNCT07275710Not applicable
- An Extension Test of Whether to Use Oral Anti-anxiety Drugs (Alprazolam) When Patients Choose Second Eye Cataract Surgery After Unblinding, and Analyze Their Anxiety, Satisfaction and Pain SatisfactionRecruitingNCT06874452Phase 4
- Anxiety and Surgery Satisfaction for Cataract Patient With Different State AnxietyRecruitingNCT06826417Not applicable
- Opioid Drug Interaction StudyRecruitingNCT06757140Phase 1/2
- A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged SeizuresRecruitingNCT05077904Phase 3
- A Study to Test the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged SeizuresEnrolling by invitationNCT05076617Phase 3
- Opioid/Benzodiazepine Polydrug Abuse: Aim 3RecruitingNCT05006079Phase 2
- Validation of the Drug Impaired Driving Scenario (DIDS) on the CRCDS-miniSimCompletedNCT04970342Phase 1Results posted
- Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure PatternCompletedNCT03478982Phase 2Results posted
- Opiates and Benzodiazepines on DrivingCompletedNCT03447353Phase 4Results posted
- Sedative-Anxiolytic Effects on Simulated Driving PerformanceCompletedNCT03297944Phase 4Results posted
- Spectroscopic Imaging at 4T: A Drug Challenge StudyTerminatedNCT01577706Not applicableResults posted
- Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Non-fasting ConditionsCompletedNCT00830024Phase 1Results posted
- Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Fasting ConditionsCompletedNCT00829426Phase 1Results posted
- Efficacy of Aerobic Exercise Added to Alprazolam in Panic Disorder TreatmentCompletedNCT00803400Phase 4Results posted
- PharmacofMRI (Functional Magnetic Resonance Imaging) of Anxiolytic Medications (Alprazolam)CompletedNCT00703885Phase 4Results posted
- Drug Treatment Validation of Functional Magnetic Resonance Imaging in Generalized Anxiety DisorderCompletedNCT00662259Phase 4Results posted
- Staccato Alprazolam Abuse LiabilityCompletedNCT00603980Phase 1Results posted
- Staccato Alprazolam in Panic AttackCompletedNCT00477451Phase 2Results posted
- Trial to Compare Time to Response in the Symptoms of Anxiety to Concomitant Treatment With Niravam™ and an SSRI or SNRI to Treatment With an SSRI or SNRI Alone in Subjects With Generalized Anxiety Disorder or Panic DisorderCompletedNCT00266409Phase 4Results posted
- Abuse Potential of Oral Gabapentin in Healthy, Non-Drug-Dependent Individuals With Recreational Sedative Drug Use ExperienceCompletedNCT07777965Phase 4
- Oral vs IV Sedation for Cataract Surgery in Older AdultsCompletedNCT07154147Phase 4
- A Study to Assess the Time to Onset of Action of Staccato Alprazolam Versus Midazolam and Diazepam in Healthy ParticipantsCompletedNCT07020988Phase 1
- Detoxification From the Lipid TractCompletedNCT06357104Phase 4
- A Relative Bioavailability Study of Staccato Alprazolam Versus Oral Alprazolam in Healthy Study ParticipantsCompletedNCT05626439Phase 1
- A Study to Assess the Pharmacokinetics (PK) and Safety of Staccato Alprazolam in Adolescent Study Participants With EpilepsyCompletedNCT04857307Phase 1
- A Study to Assess the Pulmonary Safety of Staccato Alprazolam in Healthy Study Participants and in Study Participants With Mild AsthmaCompletedNCT04802746Phase 1
- Study to Assess the Safety, Tolerability, And Pharmacokinetics of Staccato Alprazolam in Healthy Japanese, Chinese, and Caucasian ParticipantsCompletedNCT04782388Phase 1
- Role of Alprazolam in the Management of Acute Coronary SyndromeStatus unknownNCT04715269Phase 1/2
- Preoperative Use of Alprazolam and Hydroxyzine in AnxietyStatus unknownNCT04184141Phase 4
- Sedative Premedication in Coronary AngiographyStatus unknownNCT03576456Not applicable
- Preoperative Hypnosis Versus Premedication in Gynecological SurgeryStatus unknownNCT03327506Phase 4
- Premedication With Alprazolam and Midazolam for Upper Gastrointestinal EndoscopyCompletedNCT03130842Phase 2/3
- Pharmacovigilance in Gerontopsychiatric PatientsTerminatedNCT02374567Phase 3
- Alprazolam as Conscious Sedation for Upper Gastrointestinal EndoscopyCompletedNCT01949038Phase 2/3
- Bioequivalence Trial of Alprazolam 0.25 mg TabletsCompletedNCT01853956Phase 1
- Imaging the Effects of Zolpidem and Alprazolam in Healthy Volunteers at 3TStatus unknownNCT01747590Early Phase 1
- Bioequivalence Trial of Alprazolam 2 mg TabletsCompletedNCT01745575Phase 1
- Bioequivalence Trial of Alprazolam 0.5 mg TabletsCompletedNCT01745562Phase 1
- Reassessment of Premedication in SurgeryCompletedNCT01549691Phase 4
- Effects of Buspar on Depressive Symptom Improvement and Neuroprotection in Patients With Anxiety DisorderWithdrawnNCT01546896Phase 4
- Effect of Alprazolam on the Success of Inferior Alveolar Nerve (IAN) BlockCompletedNCT01546090Phase 4
- An Bioequivalence Study Of Xanax Extended Release Tablets From Two Different Manufacturing SitesCompletedNCT01330472Phase 1
- A Relative Bioavailability Study of 2 mg Alprazolam OD Tablets Under Non-Fasting ConditionsCompletedNCT01188057Phase 1
- A Relative Bioavailability Study of 2 mg Alprazolam OD Tablets Under Fasting ConditionsCompletedNCT01188031Phase 1
- A Study Of Two Oral Preparations Of 2 Mg Alprazolam In Healthy Volunteers Under Fasting ConditionsWithdrawnNCT01046162Phase 1
- Bioequivalence Study Comparing Two Alprazolam 1 mg TabletsCompletedNCT00878865Phase 1
- Bioequivalence Study Comparing Two Alprazolam 1 mg Tablets Under Fed ConditionsCompletedNCT00878514Phase 1
- A Relative Bioavailability Study of Alprazolam 3 mg ER Tablets Under Fasting ConditionsCompletedNCT00865761Phase 1
- A Relative Bioavailability Study of Alprazolam 3 mg Extended Release Tablets Under Non-fasting ConditionsCompletedNCT00865657Phase 1
- Bioequivalence of Alprazolam Sublingual vs Oral TabletsCompletedNCT00860119Phase 1
- Evaluate Pharmacokinetics Of Two Different Pharmaceutical Oral Formulations Of Alprazolam And A Clonazepam Tablet In Mexican Healthy PopulationCompletedNCT00810316Phase 1
- Fed Study of Alprazolam Extended-release Tablets 3 mg to Xanax XR® Tablets 3 mgCompletedNCT00650299Phase 1
- Fasting Study of Alprazolam Extended-Release Tablets 1 mg to Xanax XR Tablets 1 mgCompletedNCT00647894Phase 1
- Fasting Study of Alprazolam Extended-Release Tablets 3 mg to Xanax XR® Tablets 3 mgCompletedNCT00647634Phase 1
- A Study to Evaluate the Use of Extended Release Alprazolam in the Treatment of Adolescents With Panic DisorderTerminatedNCT00635531Phase 4
- A Study to Assess the Long-term Use of Alprazolam Extended Release (XL) in the Treatment of Adolescents With Panic DisorderTerminatedNCT00635076Phase 4
- A Study To Assess the Safety of Extended Release Alprazolam for the Treatment of Adolescents With Panic Disorder or Anxiety With Panic AttacksTerminatedNCT00634790Phase 4
- Hypoglycemia Associated Autonomic Failure in Type 1 DM, Q2CompletedNCT00592332Not applicable
- Mechanisms of Hypoglycemia Associated Autonomic Dysfunction Question 2CompletedNCT00574639Early Phase 1
- To Investigate Effects GSK561679 on Part of the Body's System That Controls the Balance of Many of the Hormones.CompletedNCT00426608Phase 1
- Trial of Pregabalin, Alprazolam, and Placebo in Subjects With Anxiety Prior to Dental ProcedureCompletedNCT00245609Phase 2
- A Study of Sertraline and Early Alprazolam XR Administration Versus Sertraline Only in Panic Disorder PatientsCompletedNCT00198094Phase 4
- Phase II Double-Blind, Placebo-Controlled Study of the Reinforcing Effects of Alprazolam in Patients With AnxietyCompletedNCT00004373Phase 2